ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+2.22%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$250M
AUM Growth
+$250M
(-51%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-95.17%
Top 10 Holdings %
Top 10 Hldgs %
82.54%
Holding
56
New
3
Increased
2
Reduced
13
Closed
17
Top Buys
| 1 |
KalVista Pharmaceuticals
KALV
|
$2.85M |
| 2 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$1.63M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$1.16M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$429K |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$140K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$56.1M |
| 2 |
argenx
ARGX
|
$26.4M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$20.3M |
| 4 |
Ascendis Pharma
ASND
|
$17M |
| 5 |
Veracyte
VCYT
|
$15M |
Sector Composition
| 1 | Healthcare | 81.68% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vericel Corp
VCEL
$1.83B
| – | – | -190,055 | Closed | -$1.84M |
|
52
Viking Therapeutics
VKTX
$3.04B
| – | – | -750,000 | Closed | -$7.12M |
|
53
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
|
CUTR
54
DELISTED
Cutera, Inc.
CUTR
| – | – | -105,000 | Closed | -$4.23M |
|
|
ASXC
55
DELISTED
Asensus Surgical, Inc.
ASXC
| – | – | 0 | – | – |
|